Quantifying tumor-selective radiation dose enhancements using gold nanoparticles: A monte carlo simulation study

Biomedical Microdevices

Volumn 11, Issue 4, 2009, Pages 925-933

  Zhang, Sean X ^a   Gao, Junfang ^a   Buchholz, Thomas A ^a   Wang, Zhonglu ^a   Salehpour, Mohammad R ^a   Drezek, Rebekah A ^b   Yu, Tse Kuan ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Rice University   (United States)

Author keywords

Dose enhancement; Monte Carlo simulation modeling; Nanoparticle

Indexed keywords

BENCHMARK TESTS; BIOLOGICAL EFFECTIVE DOSE; BRACHYTHERAPY; CALCULATION MODELS; COMPARISON STUDY; DOSE ENHANCEMENT; DOSE-RATE; ENHANCEMENT EFFECTS; GEANT4 CODE; GOLD NANOPARTICLES; GOLD NANOSPHERES; MONTE CARLO CALCULATION; MONTE CARLO SIMULATION; MONTE CARLO SIMULATION MODELING; RADIAL DOSE FUNCTION; RADIATION DOSE; SIMULATION MODEL; TWO-DIMENSIONAL; WATER MIXTURE; WATER PHANTOM;

COMPUTER SIMULATION LANGUAGES; COSMIC RAY DETECTORS; DOSIMETRY; GOLD; IRIDIUM; LABELS; MONTE CARLO METHODS; NANOPARTICLES; NANOSPHERES; RADIATION EFFECTS; RATE CONSTANTS; TUMORS;

SIMULATORS;

GOLD; GOLD NANOPARTICLE; IRIDIUM 192; NANOSPHERE; WATER;

ACCURACY; ANISOTROPY; ARTICLE; BRACHYTHERAPY; CONTROLLED STUDY; DOSIMETRY; LABELING INDEX; MATHEMATICAL MODEL; METHODOLOGY; MONTE CARLO METHOD; PHANTOM; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIATION DOSE DISTRIBUTION;

ANIMALS; BRACHYTHERAPY; DOSE FRACTIONATION; GOLD; HUMANS; IRIDIUM RADIOISOTOPES; METAL NANOPARTICLES; MODELS, THEORETICAL; MONTE CARLO METHOD; NEOPLASMS;

EID: 68149154889     PISSN: 13872176     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10544-009-9309-5     Document Type: Article

References (31)

1. S. Agostinelli, J. Allison, K. Amako et al., Geant4 - a simulation toolkit. Nucl. Instrum. Methods Phys. Res. A 506, 250-303 (2003). doi: 10.1016/S0168-9002(03)01368-8
2. J. Allison, K. Amako, J. Apostolakis et al., Geant4 developments and applications. IEEE Trans. Nucl. Sci. 53, 270-278 (2006). doi: 10.1109/ TNS.2006.869826
3. A. Angelopoulos, P. Baras, L. Sakelliou et al., Monte Carlo dosimetry of a new Ir-192 high dose rate brachytherapy source. Med. Phys. 27, 2521-2527 (2000). doi: 10.1118/1.1315316
4. F. Ballester, C. Hernández, J. Pèrez-Calatayud et al., Monte Carlo calculation of dose rate distributions around Ir-192 wires. Med. Phys 24, 1221-1228 (1997). doi: 10.1118/1.598142
5. F. Ballester, J. Pèrez-Calatayud, V. Puchades et al., Monte Carlo dosimetry of Buchler high dose rate Ir-192 source. Med. Phys 28, 2586-2591 (2001). doi: 10.1118/1.1420398
6. K. Bullis, Remotely activated nanoparticles destroy cancer. Technology Review 2007. http://www.technologyreview.com/Nanotech/17956/. Published January 2, 2007. Accessed November 25, 2007
7. S.H. Cho, Estimation of tumor dose enhancement due to gold nanoparticles during typical radiation treatments: A preliminary Monte Carlo study. Phys. Med. Biol 50, N-163-N-173 (2005)
8. S.J. Douglas, S.S. Davis, L. Illum, Nanoparticles in drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 3, 133-161 (1987)
9. A.M. Gobin, M.H. Lee, N.J. Halas et al., Nano Lett 7, 1929-1934 (2007). doi: 10.1021/nl070610y
10. D. Granero, J. Pèrez-Calatayud, F. Ballester, Monte Carlo calculation of the TG-43 dosimetric parameters of a new BEBIG Ir-192 HDR source. Radiother. Oncol 76, 79-85 (2005). doi: 10.1016/ j.radonc.2005.06.016
11. J.F. Hainfeld, D.N. Slatkin, H.M. Smilowitz, The use of gold nanoparticles to enhance radiotherapy in mice. Phys. Med. Biol. 49, 309-N-315 (2004)
12. J.F. Hainfeld, D.N. Slatkin, T.M. Focella et al., Gold nanoparticles: A new X-ray contrast agent. Br. J. Radiol. 79, 248-253 (2006). doi: 10.1259/bjr/13169882
13. D.M. Herold, I.J. Das, C.C. Stobbe et al., Gold microspheres: A selective technique for producing biologically effective dose enhancement. Int. J. Radiat. Biol 76, 1357-1364 (2000). doi: 10.1080/ 09553000050151637
14. M. Hu, J.Y. Chen, Z.Y. Li et al., Gold nanostructures: Engineering their plasmonic properties for biomedical applications. Chem. Soc. Rev 35, 1084-1094 (2006). doi: 10.1039/b517615h
15. H.E. Johns, J.W. Hunt, S.O. Fedoruk, Surface back-scatter in the 100 kV to 400 kV range. Br. J. Radiol. 27, 443-448 (1954)
16. K.L. Kelly, E. Coronado, L.L. Zhao et al., The optical properties of metal nanoparticles: The influences of size, shape, and dielectric environment. J Phys Chem B Condens Matter Mater Surf Interfaces Biophys 107, 668-677 (2003)
17. C. Loo, A. Lowery, N. Halas, J. West, R. Drezek, Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett. 5(4)), 709-711 (2005). doi: 10.1021/nl050127s
18. R. Nath, L.L. Anderson, G. Luxton et al., Dosimetry of interstitial brachytherapy source: Recommendations of AAPM radiation therapy committee task group No. 43. Med. Phys 22, 209-234 (1995). doi: 10.1118/ 1.597458
19. C. Noguez, Surface plasmons on metal nanoparticles: The influence of shape and physical environment. J. Phys. Chem. C. Nanomaterials Interfaces 111, 3806-3819 (2007)
20. NuDat 2.4. National Nuclear Data Center. Nuclear data from NuDat, a web-based database maintained by the National Nuclear Data Center. Upton, NY, USA: Brookhaven National Laboratory; http://www.nndc.bnl.gov/ nudat2. Accessed November 25, 2007
21. J. Panyam, V. Labhasetwar, Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev 55, 329-347 (2003). doi: 10.1016/S0169-409X(02)00228-4
22. Physics Laboratory, National Institute of Standards and Technology., Stopping-power and range tables for electrons. http://physics.nist.gov/ PhysRefData/Star/Text/ESTAR.html. Accessed November 25, 2007
23. M.J. Rivard, B.M. Coursey, L.A. Dewerd et al., Update of AAPM task group No. 43 report: A revised AAPM protocol for brachytherapy dose calculations. Med. Phys. 31, 633-674 (2004). doi: 10.1118/1.1646040
24. J.L. Robar, Generation and modeling of megavoltage photon beams for contrast-enhanced radiation therapy. Phys. Med. Biol 51, 5487-5504 (2006). doi: 10.1088/0031-9155/51/21/007
25. J.L. Robar, S.A. Riccio, M.A. Martin, Tumor dose enhancement using modified megavoltage photon beams and contrast media. Phys. Med. Biol 47, 2433-2449 (2002). doi: 10.1088/0031-9155/47/14/305
26. J.H. Sakamoto, B.R. Smith, B. Xie et al., The molecular analysis of breast cancer utilized targeted nanoparticle based ultrasound contrast agents. Technol. Cancer Res. Treat. 4, 627-636 (2005)
27. G. Schmid, Nanoparticles: From theory to application (Wiley-Vch Verlag GmbH & Co. KGaA; Weinheim, Germany, 2004)
28. D.C. Sullivan, M. Ferrari, Nanotechnology and tumor imaging: Seizing an opportunity. Mol. Imaging 3, 364-369 (2004). doi: 10.1162/ 1535350042973526
29. F. Verhaegen, B. Reniers, E. Deblois et al., Dosimetric and microdosimetric study of contrast-enhanced radiotherapy with kilovolt X-rays. Phys. Med. Biol 50, 3555-3569 (2005). doi: 10.1088/0031-9155/50/ 15/005
30. J.F. Williamson, Monte Carlo evaluation of kerma at a point for photon transport problems. Med. Phys. 14, 567-576 (1987). doi: 10.1118/1.596069
31. X-5 Monte Carlo Team, MCNP-A General Monte Carlo N-Particle Transport Code, Version 5. LA-UR-03-1987. Los Alamos National Laboratory: Los Alamos, NM, 2004